Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide in Relapsed/Refractory PTCL
NCT02495415Phase 2Unknown
- Sponsor
- CerRx
- Start
- Dec 2016
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenretinide in peripheral T-cell lymphoma (PTCL), sponsored by CerRx. Status: unknown.
02
Drugs
fenretinide
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT02495415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02495415.